References and Notes
1 CDRI communication number 7186.
2a
Brase S.
Gil C.
Knepper K.
Bioorg. Med. Chem. Lett.
2002,
10:
2415
2b
Balaban AT.
Oniciu DC.
Katritzky AR.
Chem. Rev.
2004,
104:
2777
2c
Costantino L.
Barlocoo D.
Curr. Med. Chem.
2006,
13:
1
3a
Kundu B.
Sawant D.
Partani P.
Kesarwani AP.
J. Org. Chem.
2005,
70:
4889
3b
Duggineni S.
Sawant D.
Saha B.
Kundu B.
Tetrahedron
2006,
62:
3228
3c
Sawant D.
Kumar R.
Maulik P.
Kundu B.
Org. Lett.
2006,
8:
1525
3d
Saha B.
Kumar R.
Maulik P.
Kundu B.
Tetrahedron Lett.
2006,
47:
2765
4a
Buckle DR.
Rockell CJM.
J. Chem. Soc., Perkin Trans. 1
1982,
627
4b
Buckle DR.
Outred DJ.
Rockell CJM.
Smith H.
Spicer BA.
J. Med. Chem.
1983,
26:
251
4c
Buckle DR.
Outred DJ.
Rockell CJM.
Smith H.
Spicer BA.
J. Med. Chem.
1986,
29:
2262
4d
Genin MJ.
Allwine DA.
Anderson DJ.
Barbachyn MR.
Emmert DE.
Garmon SA.
Graber DR.
Grega KC.
Hester JB.
Hutchinson DK.
Morris J.
Reischer RJ.
Ford CW.
Zurenko GE.
Hamel JC.
Schaadt RD.
Stapert D.
Yagi BH.
J. Med. Chem.
2000,
43:
953
4e
Alvarez R.
Velazquez S.
San-Felix A.
Aquaro S.
De Clercq E.
Perno CF.
Karlsson A.
Balzarini J.
Camarasa MJ.
J. Med. Chem.
1994,
37:
4185
5a
Kolb HC.
Sharpless KB.
Drug Discovery Today
2003,
8:
1128
5b
Horne WS.
Stout CD.
Ghadiri MR.
J. Am. Chem. Soc.
2003,
125:
9372
5c
Horne WS.
Yadav MK.
Stout CD.
Ghadiri MR.
J. Am. Chem. Soc.
2004,
126:
15366
6
Brockunier LL.
Parmee ER.
Ok HO.
Candelore MR.
Cascieri MA.
Colwell LF.
Deng L.
Feeney WP.
Forrest MJ.
Hom GJ.
MacIntyre DE.
Tota L.
Wyvratt MJ.
Fisher MH.
Weber AE.
Bioorg. Med. Chem. Lett.
2000,
10:
2111
7
Huisgen R. In 1,3-Dipolar Cycloaddition Chemistry
Padwa A.
Wiley;
New York:
1984.
8a
Rostovtsev VV.
Green LG.
Fokin VV.
Sharpless KB.
Angew. Chem. Int. Ed.
2002,
41:
2596
8b
Tornoe CW.
Christensen C.
Meldal M.
J. Org. Chem.
2002,
67:
3057
9a
Horne WS.
Yadav MK.
Stout CD.
Ghadiri MR.
J. Am. Chem. Soc.
2004,
126:
15366
9b
Manetsch R.
Krasinski A.
Radic Z.
Raushel J.
Taylor P.
Sharpless KB.
Kolb HC.
J. Am. Chem. Soc.
2004,
126:
12809
9c
Zhou Z.
Fahrni CJ.
J. Am. Chem. Soc.
2004,
126:
8862
9d
Punna S.
Kuzelka J.
Wang Q.
Finn MG.
Angew. Chem. Int. Ed.
2005,
44:
2215
10
Bock VD.
Hiemstra H.
Maarseveen JHV.
Eur. J. Org. Chem.
2006,
51
11a
Rostovtsev VV.
Green LG.
Fokin VV.
Sharpless KB.
Angew. Chem. Int. Ed.
2002,
114:
2708
11b
Chan TR.
Robert H.
Sharpless KB.
Fokin VV.
Org. Lett.
2004,
6:
2653
11c
Feldman AK.
Colasson B.
Fokin VV.
Org. Lett.
2004,
6:
3897
12
Prasad A.
Wim D.
Fokin VV.
Eycken EV.
Org. Lett.
2004,
6:
4223
13
Chan TR.
Hilgraf R.
Sharpless KB.
Fokin VV.
Org. Lett.
2004,
6:
2853
14a
Atkins PW.
Physical Chemistry
6Rev ed.:
Oxford University Press;
Oxford:
1998.
p.243-278
14b
Dekock RLJ.
Chem. Educ.
1996,
73:
955
14c
Craw DR.
Principles and Application of Electrochemistry
Blackie;
London:
1994.
15a
Prasad A.
Wim D.
Fokin VV.
Eycken EV.
Org. Lett.
2004,
6:
4223
15b
Zhao YB.
Yan ZY.
Liang YM.
Tetrahedron Lett.
2006,
47:
1545
15c
Maksikova AV.
Serebryakova ES.
Tikhonova LG.
Vereshagin LI.
Chem. Heterocycl. Compd. (Engl. Trans.)
1980,
1284
16
Saha B.
Sharma S.
Sawant D.
Kundu B.
Tetrahedron Lett.
2007,
48:
1379
17
Rideout DC.
Breslow RL.
J. Am. Chem. Soc.
1980,
102:
7816
18
Yan ZY.
Zhao YB.
Fan MJ.
Liu VM.
Liang YM.
Tetrahedron
2005,
61:
9331
19
General Procedure for the Preparation of 1-(2-Nitrophenyl)-4-phenyl-1
H
-[1,2,3]triazole (
3a): 1-Fluoro-2-nitrobenzene (2.0 mmol), phenylacetylene (2.2 mmol), sodium azide (2.2 mmol) and NaHCO3 (2.2 mmol) were suspended in H2O (10 mL) in a 50-mL round-bottomed flask equipped with a small magnetic stirring bar. To this was added copper powder (100 mg) and ferric chloride (100 mg). The mixture was then heated to reflux for 7 h. The reaction mixture was cooled and EtOAc (50 mL) was added. The suspension was passed through a bed of celite and the filtrate was partitioned in a separating funnel. The organic layer was separated, dried (Na2SO4) and concentrated to afford a residue, which was purified by silica gel chromatography using hexane-EtOAc (70:30) as eluent to afford 3a as a yellow solid. Yield: 72%; mp 144-145 °C. IR (KBr): 1604, 1534, 1351 cm-1. 1H NMR (300 MHz, CDCl3): δ = 8.12 (dd, J = 1.2, 7.9 Hz, 1 H, ArH), 8.09 (s, 1 H, ArH), 7.91-7.94 (m, 2 H, ArH), 7.81-7.84 (m, 1 H, ArH), 7.69-7.76 (m, 2 H, ArH), 7.46-7.51 (m, 2 H, ArH), 7.40-7.43 (m, 1 H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 148.54, 144.60, 134.01, 130.91, 130.41, 129.96, 129.11, 128.81, 128.03, 126.15, 125.73, 121.18. MS (ES+): m/z = 267.1 [M+ + 1]. Anal. Calcd for C14H10N4O2: C, 63.15; H, 3.79; N, 21.04. Found: C, 63.26; H, 3.57; N, 21.40.
1-(4-fluoro-2-nitrophenyl)-4-phenyl-1H-[1,2,3]triazole (3b): Yield: 75%; mp 178-180 °C. IR (KBr): 1601, 1523, 1347 cm-1. 1H NMR (300 MHz, DMSO): δ = 9.14 (s, 1 H, ArH), 8.28 (dd, J = 2.4, 8.0 Hz, 1 H, ArH), 8.04-8.08 (m, 1 H, ArH), 7.89-7.94 (m, 3 H, ArH), 7.51 (t, J = 7.2 Hz, 2 H, ArH), 7.27-7.42 (m, 1 H, ArH), 13C NMR (75.5 MHz, DMSO): δ = 147.08, 144.75, 129.78, 129.60, 129.03, 128.43, 125.79, 125.37, 122.91, 121.60, 121.30, 113.80, 113.42. MS (ES+): m/z = 285.2.